Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Organon
Pharma
Sun-Organon, Astellas, BeOne—Fierce Pharma Asia
Sun will buy Organon for $11.75 billion. Astellas projects Xtandi sales declines in FY2026. BeOne has eyes on a PD-1xCTLA-4xVEGF trispecific antibody.
Angus Liu
May 1, 2026 8:43am
Sun Pharma snaps up women's health leader Organon for $11.75B
Apr 27, 2026 11:06am
Poherdy, first biosimilar to Roche's Perjeta, scores FDA nod
Nov 14, 2025 10:52am
UK watchdog slams AstraZeneca, Organon for marketing breaches
Oct 27, 2025 11:00am
Organon hunts for new CEO after probe exposes sales misconduct
Oct 27, 2025 10:00am
Organon taps into 'romantasy' craze with new Nexplanon ad
May 13, 2025 2:10pm
